Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

17.40 +0.18 (+1.05%)
Streaming Delayed Price Updated: 1:58 PM EDT, Mar 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bausch + Lomb Corporation Common Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
Bausch & Lomb Earnings Preview ↗
 
Via Benzinga
News headline image
Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month ↗
"Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital predicts $1.159 billion revenue. Insights on Miebo launch and enhanced EBITDA margins... 
Via Benzinga
News headline image
The Latest Analyst Ratings for Bausch & Lomb ↗
 
Via Benzinga
News headline image
Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News' ↗
U.S. stocks could start Wednesday's session lower as traders stay cautious ahead of the Fed decision and more earnings. 
Via Benzinga
Topics Economy Stocks
News headline image
Bausch & Lomb Earnings Preview ↗
 
Via Benzinga
News headline image
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week ↗
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
News headline image
6 Analysts Have This to Say About Bausch & Lomb ↗
 
Via Benzinga
News headline image
Earnings Preview: Bausch & Lomb ↗
 
Via Benzinga
News headline image
Novartis Mulls Divesting Some Assets Of Radiopharma Unit In Strategic Shift ↗
Swiss pharmaceutical giant Novartis AG (NYSE: NVS) is reportedly contemplating selling sections of radiopharmaceuticals company Advanced Accelerator Applications to align with the company's strategy... 
Via Benzinga
News headline image
Analyst Ratings for Bausch & Lomb ↗
 
Via Benzinga
News headline image
Bausch + Lomb Expands OTC Eye Care Portfolio, Acquires JNJ's Blink ↗
Bausch + Lomb Corporation (NYSE: BLCO) has acquired Johnson & Johnson's (NYSE: JNJ) eye and contact lens drops brand Blink for $106.5 million to bolster its position in over-the-counter (OTC)... 
Via Benzinga
News headline image
Analyst Ratings for Bausch & Lomb ↗
 
Via Benzinga
News headline image
Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
9 Analysts Have This to Say About Bausch & Lomb ↗
 
Via Benzinga
News headline image
Looking Into Bausch & Lomb's Return On Capital Employed ↗
 
Via Benzinga
News headline image
Bausch & Lomb's Return On Capital Employed Insights ↗
 
Via Benzinga
News headline image
Inflationary Factors And Slow Product Uptake Could Be Headwinds For Bausch + Lomb, Analyst Says ↗
 
Via Benzinga
News headline image
Amazon Hires Dozens of Former FTC Officials, Volkswagen Discusses With Tesla to Adopt North American Charging Standard, FDA Approves First Hemophilia A BioMarin Gene Therapy: Today's Top Stories ↗
New York Post 
Via Benzinga
News headline image
Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis ↗
Bausch + Lomb Corporation (NYSE: BLCO) has agreed to acquire 'front of eye' ophthalmology assets for $1.75 billion in upfront cash, plus additional milestone payments from Novartis AG (NYSE: 
Via Benzinga
News headline image
Recap: Bausch & Lomb Q1 Earnings ↗
 
Via Benzinga
News headline image
Analyst Expectations for Bausch & Lomb's Future ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023 ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Bausch & Lomb ↗
 
Via Benzinga
News headline image
Trade Desk, Roblox, Herbalife And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
7 Analysts Have This to Say About Bausch & Lomb ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022 ↗
 
Via Benzinga
What 7 Analyst Ratings Have To Say About Bausch & Lomb ↗
 
Via Benzinga
News headline image
Expert Ratings for Bausch & Lomb ↗
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Battered FTX's CEO Sam Bankman-Fried Arrested, Elon Musk's SpaceX Mammoth Valuation Of $140B, China Weighs Over $143B In Semiconductor Push: Top Stories Tuesday, Dec. 13 ↗
Benzinga Sam Bankman-Fried Arrested In The Bahamas 
Via Benzinga
News headline image
Bausch Health Investors Request Blocking Eye-Care Business Spinoff, Alleging Protection From Lawsuits ↗
More than 50 funds that own Bausch Health Companies Inc (NYSE: BHC) investors are reportedly seeking to block the eye-care business spin-off, Bausch + Lomb Corp (NYSE: BLCO). 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.